External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CMSC 2025

-
Coming soon
09:20 PM
Duration 40mins North 121 ABC
Placental and Breastmilk Transfer of Ocrelizumab From Women With Multiple Sclerosis to Infants and Potential Impact on B-Cell Levels: The MINORE and SOPRANINO Trials
Bove, Riley; Oreja-Guevara, Celia; Vukusic, Sandra; Shah, Anna; Graham, Edith L.; McElrath, Thomas; Pietrasanta, Carlo; Dobson, Ruth; Maillart, Elisabeth; Jacobs, Dina; Kletzl, Heidemarie; Kazlauskaite, Agne; Alves, Daniela; Raposo, Catarina; Craveiro, Licinio; Lin, Chien-Ju; Pasquarelli, Noemi; Hellwig, Kerstin

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:20 PM
Duration 40mins North 121 ABC
Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results From the FENopta Open-Label Extension
Bar-Or, Amit; Oh, Jiwon; Dufek, Michal; Budincevic, Hrvoje; Habek, Mario; Caunt, Maresa; Harp, Christopher; Sierzega, Malgorzata; Clayton, David; Chen, Ying-Fang; Ratchford, John N.; Goodyear, Alexandra; Drulovic, Jelena

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:00 PM
Duration 120mins Phoenix, USA
Fatigue and Cognition Burden Among Black and African American and Hispanic and Latino People With Relapsing Multiple Sclerosis Receiving Ocrelizumab for 2 Years
Williams, Mitzi; Chinea, Angel; Amezcua, Lilyana; Pandey, Krupa; Cuascut, Fernando; Goldstick, Lawrence; Hooker, Juzar; Monson, Nancy; Bernitsas, Evanthia; Reder, Anthony; Wu, Gregory; Pei, Jinglan; Abioye, Ibraheem; Vartanian, Tim

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Phoenix, USA
Geographic Disparities in Spatial Access to Outpatient Infusion Providers Among People With Multiple Sclerosis in the US
Pineda, Elmor D.; Majda, Thomas; Xia, Zhiyu; Wang, Rongrong

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Phoenix, USA
Ocrelizumab Subcutaneous Administration: Further Characterization of the Benefit–Risk Profile From the OCARINA II Study and Patient Preferences
Newsome, Scott D.; Goldstick, Lawrence; Selmaj, Krzysztof; Krzystanek, Ewa; Zecevic, Dusanka; Figueiredo, Catarina; Clinch, Susanne; Giacobino, Caroline; Azmi, Jay; Centonze, Diego

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Phoenix, USA
Ocrelizumab Treatment in Multiple Sclerosis: 11-Year Efficacy and Safety Clinical Trial Data
Hauser, Stephen L; Kappos, Ludwig; Weber, Martin; Nicholas, Jacqueline; Schneble, Hans-Martin; Craveiro, Licinio; Chognot, Cathy; Pasquarelli, Noemi; Wang, Qing; Bermel, Robert

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Phoenix, USA
MRI-Supported Relapses As a Potential Relapsing Multiple Sclerosis (RMS) Trial Outcome Measure: Use in the OPERA I and II Trials with Ocrelizumab
Alvarez, Enrique; Priest, Jessica; Hennon, Sierra; Bakdache, Fabien; Wang, Qing; Craveiro, Licincio; Krieger, Stephen

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:00 PM
Duration 15mins Phoenix Convention Center
Efficacy and Safety of a Body-Weight–Adjusted High Dose of Ocrelizumab vs the Approved Dose in Relapsing Multiple Sclerosis: Primary Results of the Phase IIIb MUSETTE Study
Hauser, Stephen; Bar-Or, Amit; Sormani, Maria Pia; Giovannoni, Gavin; Oh, Jiwon; Stoll, Sharon; Weber, Martin; Montalban, Xavier; Selmaj, Krzysztof; Maciejowski, Maciej; Nicholas, Jacqueline; Zecevic, Dusanka; Bonati, Ulrike; Wang, Qing; Schneble, Hans-Martin, Kappos, Ludwig

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar